Kane Biotech Inc. (KNE.V)
Develops antimicrobial wound care products that break down bacterial biofilms.
0.03-0.17%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-37.5%
The outlook
Kane Biotech is trading well below both its 50- and 200-day moving averages, sitting near the lower end of its 52-week range. The stock is down significantly from recent highs and reflects weak analyst sentiment. Current price action shows minimal daily movement amid what appears to be limited trading momentum.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range17% of the way from its 52-week low to high
Market cap
$5.1M
52-wk high
0.05
52-wk low
0.02
50-day avg
0.03
200-day avg
0.04
Trailing P/E
—